TNFSF11 and osteoporosis: Other antiresorptive drugs that can serve as alternatives for osteoporosis treatment include denosumab, a RANKL inhibitor that blocks the main pathway involved in osteoclast formation and activation [112], and calcitonin, a naturally occurring peptide [113].